Remove Biopharma Remove Healthcare Remove Pharmaceutical products Remove Side effects
article thumbnail

Practical advice for Early Scientific Advice (ESA) in HTA submissions

pharmaphorum

A step-by step guide on the benefits, processes, and key considerations involved in the Healthcare Technology Assessment (HTA) Early Scientific Advice (ESA) consultation as part of planning the holistic evidence generation to support the design of an asset. In recent years, the biopharma market has become progressively complex.